NCT02106247View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of BI 1181181 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Healthy
Interventions
DRUG

BI 1181181 high dose

two tablet

DRUG

BI 1181181 low dose

one tablet

DRUG

Placebo

tablet

Trial Locations (1)

Unknown

1344.20.32001 Boehringer Ingelheim Investigational Site, Antwerp

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY